At a glance
ClinicalIndex Comparison RecordN/ACompleted· 658 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Study of Metabolism Influence in Human Alcoholic Liver Disease
In Brief
An observational study for Alcoholic Liver Disease. Completed, enrolled 658 participants across 1 site.
Detailed Summary
Increasing evidence attests the influence of multiple metabolic genetic risk factors in the progression of alcoholic liver disease. Deleterious pathways involved in metabolism such as lipid peroxidation and cytokines have been implicated in promoting inflammation leading to fibrosis increase and liver injury progression. The aim of this study was to assess the role of rs738409 single nucleotide polymorphism in the PNPLA3 gene in alcoholic liver disease patients.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsAlcoholic Liver Disease
CountriesBelgium
Collaborators--
Timeline
N/ACompletedFinished
2003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartJan 2003
Primary CompletionJan 2010
Study CompletionMar 2010
First PostedMay 2010
TodayJul 2026
First PostedMay 13, 2010
Enrollment StartJan 1, 2003
Primary CompletionJan 1, 2010
Study CompletionMar 1, 2010
TodayJul 2, 2026
Enrollment to primary: 7 yearsPosted 16.1 years ago